Share
Market Research Report

CIRCULATING CELL-FREE TUMOR DNA MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Tumor TypeMalignant Tumors · Precancerous Tumors
  • By Cancer TypeLung Cancer · Colorectal Cancer · Breast Cancer · Others) by Technology (PCR, Massively Parallel Sequencing, Single Nucleotide Polymorphism
  • By ApplicationCancer Diagnosis · Targeting Therapeutics · Prognosis Indication
  • Published In29 Apr 2026
  • Report CodeCMI5819
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Tumor Type
      • Market Snapshot, By Cancer Type
      • Market Snapshot, By Technology
      • Market Snapshot, By Application
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Highlights
    • Product Launch
    • Technological Advancements
    • PEST Analysis
    • Regulatory Scenario
    • Mergers and Acquisitions
  4. Global Circulating Cell-free Tumor DNA Market, By Tumor Type, 2021 – 2033, (US$ Billion)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Malignant Tumors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
    • Precancerous Tumors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
  5. Global Circulating Cell-free Tumor DNA Market, By Cancer Type, 2021 – 2033, (US$ Billion)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segments Trends
    • Lung Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
    • Colorectal Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
    • Breast Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
  6. Global Circulating Cell-free Tumor DNA Market, By Technology, 2021 – 2033, (US$ Billion)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segments Trends
    • PCR
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
    • Massively Parallel Sequencing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
    • Single Nucleotide Polymorphism
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
  7. Global Circulating Cell-free Tumor DNA Market, By Application, 2021 – 2033, (US$ Billion)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Cancer Diagnosis    
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
    • Targeting Therapeutics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
    • Prognosis Indication
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
  8. Global Circulating Cell-free Tumor DNA Market, By Region, 2021 – 2033, (US$ Billion)

    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Regions, 2022–2033
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Billion)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Billion)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Billion)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Billion)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Billion)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (US$ Billion)
        • North Africa
        • Central Africa
        • South Africa
  9. Competitive Landscape

    • Biocept, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Illumina, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Quest Diagnostics Incorporated
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • KURABO INDUSTRIES LTD
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • PerkinElmer chemagen Technologie GmbH
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Biodesix
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Guardant Health
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • QIAGEN
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Sequenom, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Agilent Technologies, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Fluxion Biosciences Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Natera, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Agena Bioscience, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Paragon Genomics, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Lucence Health Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Eurofins Genomics
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Thermo Fisher Scientific
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
  10. Section

    • Research Methodology
    • About Us

*Browse 35 market data tables and 34 figures on “Global Circulating Cell-free Tumor DNA Market” - Global forecast to 2033